GHTC joined 162 organizations in endorsing a letter to House and Senate leadership urging them to complete work on the fiscal year (FY) 2020 appropriations bills as soon as possible, given that the uncertainty created by short-term continuing resolutions can have “severe consequences for science and research.”
Homeland Preparedness News covered GHTC's 2019 Innovating for Impact Awards, which honored Representatives Anna Eshoo (D-CA) and Mario Diaz-Balart (R-FL).
GHTC sent a letter to House and Senate appropriators urging them to include in the final fiscal year (FY) 2020 Labor, Health and Human Services, Education, and Related Agencies bill report language emphasizing the role of the Biomedical Advanced Research and Development Authority (BARDA) in advancing R&D for naturally-occurring health threats and requesting a delineation of BARDA’s investments in this area in its annual five-year budget plan.
GHTC submitted comments to a US Department of Health and Human Services request for information (RFI) on the 2020 National Vaccine Action Plan (NVP). GHTC’s submission encouraged the continuation of R&D objectives reflected in the 2010 NVP and recommended additional areas of focus including strengthening public-private partnerships, advancing regulatory science, ensuring sustainable financing for areas that lack commercial market demand, promoting access-centered R&D, and collaborating with international partners to strengthen laboratory and clinical trial capacity.
The Global Health Technologies Coalition is greatly encouraged that yesterday’s Okayama Declaration from G20 Health Ministers contains strong support for investing in research and development initiatives to combat antimicrobial resistance and improve public health preparedness.
Statement from Jamie Bay Nishi, Director, Global Health Technologies Coalition, on the US Food and Drug Administration’s approval of pretomanid, a new drug developed by the nonprofit TB Alliance.
This legislation is an important step forward in strengthening our nation’s preparedness against global disease threats. We applaud the Administration and Congress for recognizing that protecting our nation’s health requires deploying BARDA’s unique capabilities to combat all hazards—not only chemical, biological, radiological and nuclear threats, but naturally occurring health threats as well.
GHTC has opened nominations for its 2019 Innovating for Impact Awards. Now in its third year, this initiative celebrates the partnerships and policymakers driving global health innovation. The nomination deadline is July 31, 2019.
As the year comes to a close, we are taking a look back at the top global health innovation stories and news that shaped 2019.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Faces of Innovation—a new GHTC project that features scientists on the front lines of research and development on new global health tools and technologies—profiles Hannah Wu, who we met at the American Society of Tropical Medicine and Hygiene (ASTMH) Annual Conference, who is working to develop vaccines against the neglected tropical disease schistosomiasis at Brown University.
The World Health Organization recently announced that at its upcoming Executive Board meeting in February member states will discuss challenges and issues in implementing the Nagoya Protocol—a legal framework that governs the access to and benefits gained through the sharing of genetic resources including human and animal DNA, plants, and pathogens. As these discussions heat up, GHTC is taking a brief look at what the Nagoya Protocol is, how it impacts global health R&D, and what’s next for the future of this framework.
Homeland Preparedness News covered GHTC's 2019 Innovating for Impact Awards, which honored Representatives Anna Eshoo (D-CA) and Mario Diaz-Balart (R-FL).
A commentary piece authored by GHTC Director Jamie Bay Nishi on the steady and substantial funding necessary to drive breakthrough innovations for global health threats was featured in The Hill.
The Hill quoted GHTC Director Jamie Bay Nishi in an article on Ebola vaccine development.
The Verge quoted GHTC Director Jamie Bay Nishi in an article on developing drugs and products amidst an outbreak.
CIDRAP quoted GHTC Director Jamie Bay Nishi in an article on the FDA approval of a new drug to treat highly resistant tuberculosis.
GHTC joined 162 organizations in endorsing a letter to House and Senate leadership urging them to complete work on the fiscal year (FY) 2020 appropriations bills as soon as possible, given that the uncertainty created by short-term continuing resolutions can have “severe consequences for science and research.”
GHTC sent a letter to House and Senate appropriators urging them to include in the final fiscal year (FY) 2020 Labor, Health and Human Services, Education, and Related Agencies bill report language emphasizing the role of the Biomedical Advanced Research and Development Authority (BARDA) in advancing R&D for naturally-occurring health threats and requesting a delineation of BARDA’s investments in this area in its annual five-year budget plan.
GHTC submitted comments to a US Department of Health and Human Services request for information (RFI) on the 2020 National Vaccine Action Plan (NVP). GHTC’s submission encouraged the continuation of R&D objectives reflected in the 2010 NVP and recommended additional areas of focus including strengthening public-private partnerships, advancing regulatory science, ensuring sustainable financing for areas that lack commercial market demand, promoting access-centered R&D, and collaborating with international partners to strengthen laboratory and clinical trial capacity.
GHTC endorsed a letter from the Ad Hoc Group for Medical Research urging House and Senate appropriators to work quickly to adopt a meaningful increase to the fiscal year 2020 (FY20) Labor, Health and Human Services, Education, and Related Agencies appropriations bill and provide a robust funding increase for the National Institutes of Health.
GHTC endorsed a letter from the TB Roundtable to House and Senate appropriators urging the adoption of robust funding levels for tuberculosis (TB) programs at the US Agency for International Development and Centers for Disease Control and Prevention in final fiscal year 2020 (FY20) appropriations bills. The letter also urges appropriators to restore TB as a disease eligible for funding under the Department of Defense’s Peer Reviewed Medical Research Program.
